Estrofurate
Estrofurate (INN, USAN) (developmental code name AY-11483), also known as 17α-(3-furyl)-estra-1,3,5(10),7-tetraene-3,17-diol 3-acetate, is a synthetic, steroidal estrogen that was synthesized in 1967 and studied in the late 1960s and early 1970s but was never marketed.[1][2] It is a relatively weak estrogen in bioassays.[3]
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C24H26O4 |
Molar mass | 378.468 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
References
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 503. ISBN 978-1-4757-2085-3.
- Banik UK, Revesz C, Herr F (April 1969). "Orally active oestrogens and progestins in prevention of pregnancy in rats". Journal of Reproduction and Fertility. 18 (3): 509–15. doi:10.1530/jrf.0.0180509. PMID 4182486.
- Revesz C, Banik UK, Lefebvre Y (June 1970). "AY-11483, a new type of orally active oestrogen". Journal of Reproduction and Fertility. 22 (1): 27–32. doi:10.1530/jrf.0.0220027. PMID 5421116.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.